Ik Joo Chung

TL;DR: Adjuvant treatment with capecitabine plus oxaliplatin after D2 gastrectomy should be considered for patients with operable stage II or III gastric cancer, according to a planned interim analysis.

TL;DR: Linifanib and sorafenib had similar OS in advanced HCC and the study failed to meet the primary end point, despite defined superiority and noninferiority OS boundaries being met.

TL;DR: The SOX regimen could be an alternative first-line doublet chemotherapy strategy for patients with metastatic colorectal cancer and further investigation is needed to explore its potential when used together with other targeted agents or as adjuvant chemotherapy.

TL;DR: Adjuvant chemotherapy after D2 gastrectomy is standard for resectable locally advanced gastric cancer (LAGC) in Asia as discussed by the authors, based on positive findings for perioperative chemotherapy in European ph...

TL;DR: Combination of trastuzumab and XELOX is well tolerated and highly effective in patients with HER2-positive AGC.